Interpace Biosciences, Inc. is an independent molecular diagnostics and biopharma services company. The Company is focused on providing complex molecular analysis for the early diagnosis and treatment of cancer and supporting the development of targeted therapeutics. It offers services along with the therapeutic value chain from early diagnosis and prognostic planning to target therapeutic applications through its clinical and pharma services. Its clinical services provide clinically useful molecular diagnostic tests, bioinformatics and pathology services for evaluating risk of cancer by leveraging the latest technology in personalized medicine for improved patient diagnosis and management. Its pharma services provide pharmacogenomics testing, genotyping, biorepository and other services to the pharmaceutical and biotech industries. The Company's products include ThyGenNEXT, ThyraMIR, PancraGEN, RespriDX and BarreGen.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Annual Dividend Rate
Price/Cash Flow (TTM)